157 related articles for article (PubMed ID: 8507869)
1. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix.
Benezra M; Vlodavsky I; Ishai-Michaeli R; Neufeld G; Bar-Shavit R
Blood; 1993 Jun; 81(12):3324-31. PubMed ID: 8507869
[TBL] [Abstract][Full Text] [Related]
2. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
3. Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C.
Bashkin P; Neufeld G; Gitay-Goren H; Vlodavsky I
J Cell Physiol; 1992 Apr; 151(1):126-37. PubMed ID: 1313817
[TBL] [Abstract][Full Text] [Related]
4. Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.
Klagsbrun M
Semin Cancer Biol; 1992 Apr; 3(2):81-7. PubMed ID: 1378313
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan.
Brunner G; Gabrilove J; Rifkin DB; Wilson EL
J Cell Biol; 1991 Sep; 114(6):1275-83. PubMed ID: 1654337
[TBL] [Abstract][Full Text] [Related]
6. Sulfate moieties in the subendothelial extracellular matrix are involved in basic fibroblast growth factor sequestration, dimerization, and stimulation of cell proliferation.
Miao HQ; Ishai-Michaeli R; Atzmon R; Peretz T; Vlodavsky I
J Biol Chem; 1996 Mar; 271(9):4879-86. PubMed ID: 8617759
[TBL] [Abstract][Full Text] [Related]
7. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
Saksela O; Rifkin DB
J Cell Biol; 1990 Mar; 110(3):767-75. PubMed ID: 2137829
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis.
Vlodavsky I; Fuks Z; Ishai-Michaeli R; Bashkin P; Levi E; Korner G; Bar-Shavit R; Klagsbrun M
J Cell Biochem; 1991 Feb; 45(2):167-76. PubMed ID: 1711529
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules.
Bashkin P; Doctrow S; Klagsbrun M; Svahn CM; Folkman J; Vlodavsky I
Biochemistry; 1989 Feb; 28(4):1737-43. PubMed ID: 2541764
[TBL] [Abstract][Full Text] [Related]
10. Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.
Bar-Shavit R; Eldor A; Vlodavsky I
J Clin Invest; 1989 Oct; 84(4):1096-104. PubMed ID: 2794047
[TBL] [Abstract][Full Text] [Related]
11. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes.
Chintala SK; Miller RR; McDevitt CA
Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203
[TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis.
Vlodavsky I; Korner G; Ishai-Michaeli R; Bashkin P; Bar-Shavit R; Fuks Z
Cancer Metastasis Rev; 1990 Nov; 9(3):203-26. PubMed ID: 1705486
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 stimulates the production of basic fibroblast growth factor binding proteoglycans in Balb/c3T3 cells.
Nugent MA; Edelman ER
J Biol Chem; 1992 Oct; 267(29):21256-64. PubMed ID: 1400436
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form.
Presta M; Maier JA; Rusnati M; Ragnotti G
J Cell Physiol; 1989 Jul; 140(1):68-74. PubMed ID: 2500452
[TBL] [Abstract][Full Text] [Related]
15. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
Brown KJ; Parish CR
Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity.
Nugent MA; Edelman ER
Biochemistry; 1992 Sep; 31(37):8876-83. PubMed ID: 1390674
[TBL] [Abstract][Full Text] [Related]
17. Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury.
Buczek-Thomas JA; Nugent MA
J Biol Chem; 1999 Aug; 274(35):25167-72. PubMed ID: 10455199
[TBL] [Abstract][Full Text] [Related]
18. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.
Pillarisetti S; Paka L; Obunike JC; Berglund L; Goldberg IJ
J Clin Invest; 1997 Aug; 100(4):867-74. PubMed ID: 9259586
[TBL] [Abstract][Full Text] [Related]
19. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
20. Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.
Ishai-Michaeli R; Svahn CM; Weber M; Chajek-Shaul T; Korner G; Ekre HP; Vlodavsky I
Biochemistry; 1992 Feb; 31(7):2080-8. PubMed ID: 1536850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]